Innovative approaches in Parkinson’s disease management include the use of non-invasive neuromodulation devices and wearable technologies. Stimvia’s Uris device delivering transcutaneous electrical stimulation has demonstrated symptom improvement, including tremor reduction, offering a novel therapeutic avenue. Concurrently, wearable devices have been shown in clinical trials to enhance medication adjustment precision, allowing for better symptom control. These technology-driven modalities promise to expand treatment options and personalize care strategies for patients with Parkinson’s disease.